Lorne Steinberg Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-99,860
Closed -$5M 69
2022
Q2
$5M Sell
99,860
-200
-0.2% -$10.6K 2.35% 16
2022
Q1
$5.14M Sell
100,060
-30
-0% -$1.55K 2.37% 18
2021
Q4
$5.01M Buy
+100,090
New +$4.95M 2.16% 22
2021
Q3
Sell
-98,890
Closed -$5.21M 64
2021
Q2
$5.21M Buy
98,890
+2,250
+2% +$117K 2.56% 19
2021
Q1
$4.78M Buy
96,640
+10,355
+12% +$497K 2.53% 19
2020
Q4
$4.21M Buy
+86,285
New +$4.26M 2.62% 17

Other funds holding SNY

Lorne Steinberg Wealth Management's SNY Position: Q3 2022 in Review

Lorne Steinberg Wealth Management sold out of Sanofi (SNY) in Q3 2022, closing a stake of 99,860 shares — an estimated $5M sold.

Lorne Steinberg Wealth Management first reported a position in SNY in Q4 2020 and held it in 6 quarters. The position peaked at $5.21M in Q2 2021. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Lorne Steinberg Wealth Management reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Lorne Steinberg Wealth Management sold 99,860 Sanofi shares in Q3 2022, an estimated $5M.
  • Lorne Steinberg Wealth Management first reported a position in Sanofi in Q4 2020 and held it in 6 quarters.
  • Lorne Steinberg Wealth Management's Sanofi position peaked at $5.21M in Q2 2021.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Lorne Steinberg Wealth Management's 13F filing for Q3 2022, filed 9 Nov 2022.